Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.735 USD | +0.29% | -11.48% | -42.36% |
10/05 | Ocuphire Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
11/04 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.36% | 44.43M | |
+32.36% | 694B | |
+30.77% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.77% | 239B | |
+9.13% | 209B | |
-3.97% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- OCUP Stock
- News Ocuphire Pharma, Inc.
- Transcript : Ocuphire Pharma, Inc., Q3 2023 Earnings Call, Dec 05, 2023